| RS1064796985 |
WDR19
|
Health Risk |
Likely pathogenic |
— |
| RS1064796986 |
WDR19
|
Health Risk |
Likely pathogenic |
— |
| RS1064796987 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1064796988 |
OTOGL
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1064796989 |
STXBP1
|
Health Risk |
Pathogenic |
— |
| RS1064796990 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS1064796991 |
PRPF8
|
Health Risk |
Likely pathogenic |
— |
| RS1064796993 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young type 2 |
| RS1064796995 |
KMT2D
|
Health Risk |
Pathogenic |
— |
| RS1064796996 |
EHMT1
|
Health Risk |
Pathogenic |
— |
| RS1064796998 |
BMP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Microphthalmia with brain and digit anomalies, Orofacial cleft 11 |
| RS1064797000 |
IRF6
|
Health Risk |
Pathogenic |
— |
| RS1064797001 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS1064797002 |
HDAC4
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Profound intellectual disability |
| RS1064797011 |
HNRNPU
|
Health Risk |
Pathogenic |
— |
| RS1064797012 |
ANKRD11
|
Health Risk |
Pathogenic |
— |
| RS1064797013 |
LRSAM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2P, Charcot-Marie-Tooth disease axonal type 2P |
| RS1064797015 |
PRKAR1A
|
Health Risk |
Pathogenic |
— |
| RS1064797017 |
COL3A1
|
Health Risk |
Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1064797019 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS1064797024 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS1064797027 |
GRIN1
|
Health Risk |
Pathogenic |
— |
| RS1064797028 |
NHEJ1
|
Health Risk |
Likely pathogenic |
— |
| RS1064797030 |
FOXG1
|
Health Risk |
Pathogenic |
— |
| RS1064797038 |
EP300
|
Health Risk |
Pathogenic |
— |
| RS1064797040 |
LAMA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Merosin deficient congenital muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1064797042 |
NHEJ1
|
Health Risk |
Pathogenic |
— |
| RS1064797043 |
AHDC1
|
Health Risk |
Likely pathogenic |
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome, Neurodevelopmental abnormality |
| RS1064797046 |
RNASEH2B
|
Health Risk |
Likely pathogenic |
— |
| RS1064797048 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS1064797049 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS1064797050 |
ANKRD11
|
Health Risk |
Pathogenic |
— |
| RS1064797051 |
NEXN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hypertrophic cardiomyopathy 20 |
| RS1064797052 |
ATP6V1B1
|
Health Risk |
Pathogenic |
— |
| RS1064797055 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS1064797056 |
KMT2A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1064797057 |
MEF2C
|
Health Risk |
Likely pathogenic |
— |
| RS1064797059 |
FBN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Acromicric dysplasia, Acromicric dysplasia |
| RS1064797064 |
MAP2K2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, RASopathy |
| RS1064797069 |
EFTUD2
|
Health Risk |
Pathogenic |
— |
| RS1064797071 |
PROP1
|
Health Risk |
Likely pathogenic |
Pituitary hormone deficiency, combined |
| RS1064797072 |
ATP7B
|
Health Risk |
Pathogenic/Likely pathogenic |
Wilson disease, Wilson disease |
| RS1064797073 |
CP
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of ferroxidase, Deficiency of ferroxidase |
| RS1064797074 |
DGKE
|
Health Risk |
Likely pathogenic/Pathogenic, low penetrance |
Immunoglobulin-mediated membranoproliferative glomerulonephritis, Atypical hemolytic-uremic syndrome |
| RS1064797075 |
LPL
|
Health Risk |
Likely pathogenic |
Hyperlipidemia, familial combined |
| RS1064797076 |
BSCL2
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital generalized lipodystrophy type 2, Lipodystrophy |
| RS1064797077 |
AVPR2
|
Health Risk |
Pathogenic |
Diabetes insipidus, nephrogenic |
| RS1064797078 |
COL7A1
|
Health Risk |
Pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS1064797079 |
COL7A1
|
Health Risk |
Pathogenic |
Recessive dystrophic epidermolysis bullosa, 7 conditions |
| RS1064797080 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS1064797081 |
COL7A1
|
Health Risk |
Likely pathogenic |
Recessive dystrophic epidermolysis bullosa, 7 conditions |
| RS1064797082 |
COL7A1
|
Health Risk |
Pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS1064797083 |
FLI1
|
Health Risk |
Likely pathogenic |
Bleeding disorder, platelet-type |
| RS1064797084 |
FLI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bleeding disorder, platelet-type |
| RS1064797085 |
FLI1
|
Health Risk |
Pathogenic/Likely pathogenic |
Bleeding disorder, platelet-type |
| RS1064797086 |
FLI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bleeding disorder, platelet-type |
| RS1064797087 |
FLI1
|
Health Risk |
Pathogenic |
Bleeding disorder, platelet-type |
| RS1064797088 |
GJB2
|
Health Risk |
Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 3A, Autosomal dominant nonsyndromic hearing loss 3A |
| RS1064797090 |
GJB2
|
Health Risk |
Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 3A, Autosomal dominant nonsyndromic hearing loss 3A |
| RS1064797091 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1064797092 |
DACT1
|
Health Risk |
Pathogenic |
Townes-Brocks syndrome 2, Townes-Brocks syndrome 2 |
| RS1064797093 |
LGI4
|
Health Risk |
Pathogenic |
Arthrogryposis multiplex congenita 1, neurogenic |
| RS1064797094 |
LGI4
|
Health Risk |
Pathogenic |
Arthrogryposis multiplex congenita 1, neurogenic |
| RS1064797095 |
LGI4
|
Health Risk |
Pathogenic |
Arthrogryposis multiplex congenita 1, neurogenic |
| RS1064797096 |
DIAPH1
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 1, Autosomal dominant nonsyndromic hearing loss 1 |
| RS1064797098 |
PPM1D
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold, Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold |
| RS1064797099 |
PPM1D
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold, Familial cancer of breast |
| RS1064797100 |
PPM1D
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold, Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold |
| RS1064797102 |
OTUD6B
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with dysmorphic facies, seizures |
| RS1064797103 |
OTUD6B
|
Health Risk |
Likely pathogenic |
Intellectual disability, Epilepsy |
| RS1064797104 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Rett syndrome |
| RS1064797107 |
MFN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1064797108 |
C1QB
|
Health Risk |
Likely pathogenic |
— |
| RS1064797109 |
COL9A2
|
Health Risk |
Likely pathogenic |
— |
| RS1064797111 |
POMGNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3 |
| RS1064797112 |
DOCK7
|
Health Risk |
Pathogenic |
— |
| RS1064797113 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, ABCA4-related disorder |
| RS1064797115 |
COL11A1
|
Health Risk |
Likely pathogenic |
Hearing loss, autosomal dominant 37 |
| RS1064797126 |
CRB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 12, Leber congenital amaurosis 8 |
| RS1064797128 |
CRB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis, Leber congenital amaurosis |
| RS1064797129 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2, Usher syndrome type 2 |
| RS1064797130 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2, Usher syndrome type 2 |
| RS1064797133 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS1064797134 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1064797136 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2, Usher syndrome type 2A |
| RS1064797137 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1064797138 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2, Usher syndrome type 2A |
| RS1064797148 |
PDE6C
|
Health Risk |
Conflicting classifications of pathogenicity |
Achromatopsia, Retinal dystrophy |
| RS1064797149 |
LGI1
|
Health Risk |
Likely pathogenic |
— |
| RS1064797150 |
TWNK
|
Health Risk |
Likely pathogenic |
— |
| RS1064797152 |
PGAP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperphosphatasia with intellectual disability syndrome 3, Hyperphosphatasia with intellectual disability syndrome 3 |
| RS1064797153 |
USH1C
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 1C, Autosomal recessive nonsyndromic hearing loss 18A |
| RS1064797157 |
PYGM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type V |
| RS1064797160 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1064797161 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1064797162 |
KMT2A
|
Health Risk |
Likely pathogenic |
— |
| RS1064797167 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS1064797168 |
KMT2D
|
Health Risk |
Likely pathogenic |
— |
| RS1064797169 |
KIF5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Spastic paraplegia |
| RS1064797170 |
TBK1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |